Updates

Details of updates to the guidance will be noted here, including those resulting from changes in the BNF or BNFC.

Date	Guidance update

4 June 2025	Guidance updated to reflect BNF 89 Changes are: Co-amoxiclav - change to expression of co-amoxiclav tablet dose from 250/125 to 375 mg (250/125 mg) Fungal infections - section updated to reflect changes to fluconazole dosing and management of oropharyngeal fungal infections Glucose - change to glucose doses for treatment of hypoglycaemia in adults and children
11 December 2024	Guidance updated to reflect BNF 88 and BNFC 2024-25
3 June 2024	Guidance updated to reflect BNF 87 and BNFC 2023-24. Changes are: BioXtra Gel - preparation removed as no longer listed in BNF Doxycyline - change of duration for treatment of sinusitis from 7 days to 5 days Loratidine - update to child age/weight dosing information Paracetamol - update to presentation of child age ranges
8 April 2024	Miconzaole cream - tube size amended from 20 g to 30 g
9 November 2023	Ephedrine Nasal Drops, 0.5% - preparation removed as no longer available to prescribe.